A systems biology approach to define SARS-CoV-2 correlates of protection in non-human primates

A systems biology approach to define SARS-CoV-2 correlates of protection in non-human primates

SARS-CoV-2 is expected to become a seasonal human coronavirus, with annual vaccination advised for vulnerable populations, similar to influenza. Unlike influenza, correlates of protection (CoPs) for SARS-CoV-2 have yet to be defined, which will impede the approval of new vaccines. Here, we present t...

Descripció completa

Dades bibliogràfiques
Autor principal:	Brady, C
Altres autors:	Carroll, M
Format:	Thesis
Idioma:	English
Publicat:	2024
Matèries:	Systems biology Vaccinology Immunology

Ítems similars

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
per: Pinpathomrat, N
Publicat: (2018)

Towards a universally effective HLA-E-targeted HIV vaccine - a structural and biophysical exploration
per: Walters, L
Publicat: (2019)

Evaluation of immune correlates to TB vaccines
per: Marsay, L
Publicat: (2011)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
per: Ronan, E
Publicat: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
per: Griffiths, K
Publicat: (2012)

The role of lung tissue-resident memory T cells in protection against tuberculosis
per: Bull, N
Publicat: (2017)

Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial
per: Diggle, L, et al.
Publicat: (2006)

Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children
per: Blanchard-Rohner, G, et al.
Publicat: (2010)

Biodegradable pulsatile release technologies for viral vector based vaccinations
per: Krastev, C
Publicat: (2018)

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine
per: Clutterbuck, E, et al.
Publicat: (2006)

SARS-CoV-2 mRNA Dual Immunization Induces Innate Transcriptional Signatures, Establishes T-Cell Memory and Coordinates the Recall Response
per: Ioanna Papadatou, et al.
Publicat: (2023-01-01)

Nonhuman primate antigenic cartography of SARS-CoV-2
per: Annika Rössler, et al.
Publicat: (2025-01-01)

Design and Immune Profile of Multi-Epitope Synthetic Antigen Vaccine Against SARS-CoV-2: An In Silico and In Vivo Approach
per: Maria da Conceição Viana Invenção, et al.
Publicat: (2025-01-01)

Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches
per: Cena Aram, et al.
Publicat: (2024-09-01)

Of mice and MenB: assessing the immune mechanisms underlying meningococcal capsular group B vaccines in mice
per: Sheerin, D
Publicat: (2019)

Innate immune pathways controlling IL-1beta production and adjuvant-induced T helper 17 cell differentiation
per: Shenderov, K
Publicat: (2011)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
per: Wang, LT
Publicat: (2022)

Towards the development of multi-disease vaccines against arthropod-borne viruses
per: Montalvo Zurbía Flores, G
Publicat: (2022)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
per: Warrell, M, et al.
Publicat: (2008)

A reverse vaccinology approach to the identification and characterization of Ctenocephalides felis candidate protective antigens for the control of cat flea infestations
per: Marinela Contreras, et al.
Publicat: (2018-01-01)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
per: Olotu, A
Publicat: (2013)

SARS-CoV-2 leverages airway epithelial protective mechanism for viral infection
per: Allison Marie Greaney, et al.
Publicat: (2023-03-01)

mRNA-1273 vaccination protects against SARS-CoV-2–elicited lung inflammation in nonhuman primates
per: Adam T. Waickman, et al.
Publicat: (2022-07-01)

Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
per: de Cassan, S
Publicat: (2011)

Exploiting pre-existing viral immunity for B cell vaccination against endogenous antigens
per: Wong, S
Publicat: (2013)

B cell responses to conjugate and polysaccharide meningococcal vaccines
per: Ramasamy, M
Publicat: (2012)

The role of antigen in the maintenance and localisation of CD8+ T-cells in the context of liver stage malaria
per: Gola, A
Publicat: (2018)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
per: Bauza, K
Publicat: (2012)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
per: Alharbi, N
Publicat: (2014)

Quantum vaccinomics platforms to advance in vaccinology
per: José de la Fuente, et al.
Publicat: (2023-06-01)

Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity
per: Johannes Burtscher, et al.
Publicat: (2020-10-01)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
per: Ochiai, R
Publicat: (2011)

COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants
per: Felix Wussow, et al.
Publicat: (2022-06-01)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
per: Matsumiya, M, et al.
Publicat: (2014)

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
per: Antoni Prenafeta, et al.
Publicat: (2023-07-01)

Variant- and vaccination-specific alternative splicing profiles in SARS-CoV-2 infections
per: Sung-Gwon Lee, et al.
Publicat: (2024-03-01)

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
per: Marie Alexandre, et al.
Publicat: (2022-07-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
per: Harris, S, et al.
Publicat: (2013)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
per: Hennig, B, et al.
Publicat: (2008)

Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twins
per: Lee, Y, et al.
Publicat: (2006)